Загрузка...
Benefit of pre-emptive pharmacogenetic information on clinical outcome
The development of new knowledge around the genetic determinants of variable drug action has naturally raised the question of how this new knowledge can be used to improve the outcome of drug therapy. Two broad approaches have been taken: a point-of-care approach in which genotyping for specific var...
Сохранить в:
| Опубликовано в: : | Clin Pharmacol Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134843/ https://ncbi.nlm.nih.gov/pubmed/29377064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1035 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|